ImageneBio, Inc. (IMA) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $17K. Most recent filing: Aug. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 17, 2026 filed Aug. 14, 2026 | Grant-Huerta Yanina Chief Financial Officer | $0 | 160,000 | — | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 14, 2026 | Yarema Kristin Chief Executive Officer | $0 | 642,000 | — | No | |
|
|
||||||
| July 28, 2026 filed July 25, 2026 | Yarema Kristin Chief Executive Officer | $0 | 307,010 | — | No | |
|
|
||||||
| July 20, 2026 filed July 16, 2026 | Lally Robert B Principal Accounting Officer | −$17,334 | 3,196 | −5% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free